Collegium Pharmaceutical Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
/ 
Frequently asked questions
To buy Collegium Pharmaceutical Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Collegium Pharmaceutical Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Collegium Pharmaceutical Inc. is COLL:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Collegium Pharmaceutical Inc. has its primary listing on NASDAQ. You can trade Collegium Pharmaceutical Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Collegium Pharmaceutical Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Collegium Pharmaceutical Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Collegium Pharmaceutical Inc..